Cumberland Pharmaceuticals (CPIX) Gross Profit Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Gross Profit Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.06 Bn | 87.19 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn | 5.06% |
| 3 | Zoetis | 32.51 Bn | 30.57 Bn | 1.62 Bn | 2.59% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -18.38% |
| 5 | United Therapeutics | 23.18 Bn | 21.03 Bn | 648.10 Mn | -7.66% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn | -0.34% |
| 8 | Neurocrine Biosciences | 17.75 Bn | 16.43 Bn | 800.70 Mn | 42.12% |
| 9 | Elanco Animal Health | 12.63 Bn | 12.21 Bn | 785.00 Mn | 14.77% |
| 10 | Cumberland Pharmaceuticals | 103.15 Mn | 92.14 Mn | 7.20 Mn | -30.04% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.04% |
| Dec 31, 2025 | 35.21% |
| Sep 30, 2025 | -5.92% |
| Jun 30, 2025 | 8.46% |
| Mar 31, 2025 | 48.61% |
| Dec 31, 2024 | 8.13% |
| Sep 30, 2024 | -6.70% |
| Jun 30, 2024 | -13.13% |
| Mar 31, 2024 | -13.19% |
| Dec 31, 2023 | 20.85% |
| Sep 30, 2023 | -9.45% |
| Jun 30, 2023 | 13.32% |
| Mar 31, 2023 | -11.03% |
| Dec 31, 2022 | 29.61% |
| Sep 30, 2022 | 36.24% |
| Jun 30, 2022 | 13.02% |
| Mar 31, 2022 | 10.39% |
| Dec 31, 2021 | -37.53% |
| Sep 30, 2021 | -5.11% |
| Jun 30, 2021 | 4.67% |